Back to top

genomics: Archive

Ekta Bagri

3 Top Genomics Stocks to Add to Your Portfolio in 2025

Investors interested in the Genomics and Synthetic Biology theme may consider adding these three stocks to their portfolio - Intellia Therapeutics (NTLA), uniQure (QURE) and Verve Therapeutics (VERV).

ILMNNegative Net Change BEAMNegative Net Change QURENegative Net Change NTLANegative Net Change CRSPNegative Net Change VERVNo Net Change

Zacks Equity Research

REGN Signs $256M Buyout Deal With 23andMe to Boost Genomics Research

Regeneron is set to acquire 23andMe assets for $256 million to boost genetic drug discovery. The transaction is expected to close by third-quarter 2025.

REGNPositive Net Change BAYRYPositive Net Change HALONegative Net Change ALLONegative Net Change